About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
International Journal of Neuropsychopharmacology
›
Top Articles
International Journal of Neuropsychopharmacology
Psychiatry
,
Pharmacology
,
Biology
,
Neuroscience
,
Neuropharmacology
5.8
(top 2%)
Impact Factor
6.3
(top 2%)
extended IF
112
(top 3%)
H-Index
2.1K
authors
3.2K
papers
146.7K
citations
4K
citing journals
38.7K
citing authors
Most Cited Articles of International Journal of Neuropsychopharmacology
Title
Year
Citations
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
2008
669
A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation
2011
648
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
2008
644
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
2005
449
Blood BDNF concentrations reflect brain-tissue BDNF levels across species
2011
409
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
2006
387
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
2011
378
A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression
2008
367
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis
2002
335
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder
2009
292
Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior
2016
270
Dopamine System Dysregulation in Major Depressive Disorders
2017
270
Effects of antidepressants on the production of cytokines
2002
270
Treatment non-response in OCD: methodological issues and operational definitions
2002
260
Long-term symptomatic status of bipolar I vs. bipolar II disorders
2003
259
Do we still believe in the dopamine hypothesis? New data bring new evidence
2004
253
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
2004
253
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
2014
252
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
2002
236
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
2003
226
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
2012
218
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS)
2006
215
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons
2008
208
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder
2009
207
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
2019
205
previous
2007
2008
2009
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.